CONMED
Stock Forecast, Prediction & Price Target
CONMED Financial Estimates
CONMED Revenue Estimates
CONMED EBITDA Estimates
CONMED Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $1.01B N/A | $1.04B 3.44% | $1.24B 19.06% | Avg: $1.45B Low: $1.43B High: $1.47B avg. 16.56% | Avg: $1.55B Low: $1.50B High: $1.58B avg. 7.38% | Avg: $1.68B Low: $1.62B High: $1.70B avg. 7.93% | |
Net Income
% change YoY
| $62.54M N/A | $-80.58M -228.84% | $64.45M 179.99% | Avg: $146.51M Low: $136.28M High: $158.68M avg. 127.29% | Avg: $180.93M Low: $169.72M High: $190.86M avg. 23.49% | Avg: $235.97M Low: $225.15M High: $240.35M avg. 30.42% | |
EBITDA
% change YoY
| $108.59M N/A | $-41.95M -138.63% | $192.47M 558.74% | Avg: $99.95M Low: $98.57M High: $101.33M avg. -48.06% | Avg: $107.33M Low: $103.55M High: $108.86M avg. 7.38% | Avg: $115.85M Low: $111.76M High: $117.50M avg. 7.93% | |
EPS
% change YoY
| $2.14 N/A | -$2.68 -225.23% | $2.1 178.35% | Avg: $4.68 Low: $4.32 High: $5.03 avg. 122.61% | Avg: $5.72 Low: $5.38 High: $6.05 avg. 22.24% | Avg: $7.48 Low: $7.14 High: $7.62 avg. 30.88% | |
Operating Expenses
% change YoY
| $458.31M N/A | $501.19M 9.35% | $555.64M 10.86% | Avg: $599.95M Low: $591.67M High: $608.22M avg. 7.97% | Avg: $644.24M Low: $621.51M High: $653.42M avg. 7.38% | Avg: $695.37M Low: $670.84M High: $705.28M avg. 7.93% |
FAQ
What is CONMED stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 60.40% in 2025-2027.
We have gathered data from 5 analysts. Their low estimate is 136.28M, average is 146.51M and high is 158.68M.
What is CONMED stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 10.62% in 2025-2027.
We have gathered data from 7 analysts. Their low revenue estimate is $1.43B, average is $1.45B and high is $1.47B.
What is CONMED stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 58.58% in 2025-2027.
We have gathered data from 5 analysts. Their low earnings per share estimate is $4.32, average is $4.68 and high is $5.03.
What is the best performing analyst?
In the last twelve months analysts have been covering CONMED stock. The most successful analyst is Matt O'Brien whose win rate is 50%. He has correctly predicted 1/2 price targets.